* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Activists Call For A Treaty to Share the Genetic Commons
Behavioural genetics wikipedia , lookup
Heritability of IQ wikipedia , lookup
Koinophilia wikipedia , lookup
Designer baby wikipedia , lookup
Population genetics wikipedia , lookup
Public health genomics wikipedia , lookup
Human genetic variation wikipedia , lookup
Genetic testing wikipedia , lookup
History of genetic engineering wikipedia , lookup
Genetic engineering wikipedia , lookup
Genome (book) wikipedia , lookup
Activists Call For A Treaty to Share the Genetic Commons BRIDGES Trade BioRes Vol. 2 No. 2 February 7, 2002 Biotechnology activists at a workshop held during the World Social Forum in Porto Alegre, Brazil, on 2 February launched The Treaty Initiative to Share the Genetic Commons, proclaiming that the global gene pool should be treated as a collective responsibility and a commons that must not be privatised through intellectual property rights. Supporters of the Treaty hope that it will be adopted at the Johannesburg World Summit on Sustainable Development in autumn this year and converted into a legally-binding international treaty. "We believe that our evolutionary heritage is not a commodity to be bought or sold," said Maude Barlow of the Council of Canadians, one of the organisations supporting the initiative. "All of the current arrangements and consultative initiatives based on the principle of selling prospecting rights to genetic information and extending intellectual property protection to life are unacceptable mechanisms for governing the gene pool." Vandana Shiva of the Research Foundation for Science, Technology and Ecology explains that "our initiative improves upon other international agreements dealing with this issue in one very fundamental aspect - unlike other initiatives, we oppose the extension of intellectual property rights to any living thing as well as the components of the living things." The Treaty, which has been supported by 250 NGOs from over 50 countries, is meant to counter the patenting of genes, micro-organisms, plants, animals and human parts (often referred to as 'patenting life'). In the past two decades, the extent of such patenting by biotechnology firms, universities and governments, mostly in the developed world, has increased tremendously. This enclosure of the socalled 'genetic commons' has been condemned by many NGOs and some governments on the grounds that it is said to conflict with the sovereign rights of nation states and indigenous peoples, and also that it privatises genetic information that all people should have free access to. Critics also argue that the very notion of scientists 'inventing' a life-form, seed, cell line, protein or DNA sequence is fundamentally incorrect or even sacrilegious. Other critics claim that strong patent protection in the biotechnology field may even hinder innovation. On the other hand, many companies defend such patents on the grounds that without them others could freely use their inventions and they would therefore have no incentive to invest large sums of money in research and development. The Treaty was drafted over a period of two years through a participatory process involving NGOs, political parties and parliamentarians. In order to gather and intensify global support, an international committee consisting of 18 NGOs has been set up, including well-known organisations like the Foundation on Economic Trends, the International Forum on Globalization, Centro de Educacion y Tecnología in Chile, the Indigenous Peoples' Biodiversity Network, Southeast Asia Regional Institute for Community Education (SEARICE), the Community Technology Development Trust, and Via Campesina. Background Biotechnology patenting has become an important trade issue in recent years. While the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) requires Member States to allow the patenting of micro-organisms, intellectual property protection does not have to be extended to plants or animals. As for new plant varieties, they must provide some kind of intellectual property protection, though this does not have to be a patent system. These provisions (as set out in Article 27.3b of the TRIPs Agreement) are currently being reviewed by the WTO TRIPs Council (see BRIDGES Trade BioRes, 22 November 2002, http://www.ictsd.org/biores/01-11-22/story3.htm). Most developing countries would prefer to maintain the plant and animal exceptions, and some would like also to outlaw the patenting of micro-organisms. Developed countries are generally content to leave the text as it is for the time being, though some would like to see the exceptions removed eventually. In addition to the TRIPs Agreement, the FAO International Treaty on Plant Genetic Resources for Food and Agriculture (see BRIDGES Trade BioRes, 22 November 2001; http://www.ictsd.org/biores/01-1122/story4.htm) and the Convention on Biological Diversity (CBD) also deal with the ownership and commercial use of genetic resources. Both agreements affirm the sovereign rights of national states over genetic resources and require that benefits from commercial use be shared with provider countries. Additional Resources The draft text of "The Treaty Initiative to Share the Genetic Commons" is available at http://www.sustain.org/biotech/library/admin/uploadedfiles/treaty_to_share_the_genetic_commons_the.ht m. "Hundreds of NGOs from More than 50 Nations Announce Support of a Treaty to Establish the Gene Pool as a Global Commons", PRESS RELEASE, 1 February 2002. http://www.wtowatch.org/library/admin/uploadedfiles/Hundreds_of_NGOs_from_More_than_50_Nations_ Ann.htm